Alzheimer's, spinocerebellar ataxia, and several motor neuron diseases. Recent research indicates that changes in synaptic transmission may play a critical role in the progression of neurological disease; however, the mechanisms by which the UPS regulates synaptic structure and function have not been well characterized. In this report, we show that Usp14 is indispensable for synaptic development and function at neuromuscular junctions (NMJs). Usp14-deficient ax J mice display a resting tremor, a reduction in muscle mass, and notable hindlimb rigidity without any detectable loss of motor neurons. Instead, loss of Usp14 causes developmental defects at motor neuron endplates. Presynaptic defects include phosphorylated neurofilament accumulations, nerve terminal sprouting, and poor arborization of the motor nerve terminals, whereas postsynaptic acetylcholine receptors display immature plaque-like morphology. These structural changes in the NMJ correlated with ubiquitin loss in the spinal cord and sciatic nerve. Further studies demonstrated that the greatest loss of ubiquitin was found in synaptosomal fractions, suggesting that the endplate swellings may be caused by decreased protein turnover at the synapse. Transgenic restoration of Usp14 in the nervous system corrected the levels of monomeric ubiquitin in the motor neuron circuit and the defects that were observed in the motor endplates and muscles of the ax J mice. These data define a critical role for Usp14 at mammalian synapses and suggest a requirement for local ubiquitin recycling by the proteasome to control the development and function of NMJs.
Introduction
Many pathways that are essential for the formation and function of the nervous system are regulated by the ubiquitin proteasome system (UPS). The UPS encodes hundreds of factors that specifically regulate protein degradation by the proteasome and effectively remove individual proteins from a complex cellular protein pool. This mechanism of targeted protein degradation is used for the control of numerous cellular processes including cell cycle progression, receptor signaling, and embryonic development.
The primary mechanism by which cells identify proteins for degradation by the UPS is by tagging them with a 76 aa protein called ubiquitin (Glickman and Ciechanover, 2002) . The construction of a polyubiquitin chain of four or more ubiquitins effectively targets proteins to the proteasome (Thrower et al., 2000) . Deubiquitinating enzymes act antagonistically to the ubiquitination reaction and cleave ubiquitin protein conjugates, indicating that ubiquitin modification is a reversible process similar to protein phosphorylation. Central to the degradation of proteins by the proteasome is the cell's ability to properly maintain ubiquitin pools within different cellular compartments. Since the proteasome selects proteins for degradation based on the presence of a ubiquitin side chain, loss of ubiquitin pools would severely impair the ability of the proteasome to clear unwanted proteins from the cell and result in protein accumulation.
Neuronal development relies on the UPS for specialized steps such as neuronal migration and synaptogenesis (Yi and Ehlers, 2007) , and defects in the UPS are associated with neurological disease (Alves-Rodrigues et al., 1998) . For instance, loss of an E3 ligase causes Angelman syndrome, a neurodevelopmental disorder that results in ataxia and mental retardation (Kishino et al., 1997) . X-linked infantile spinal muscular atrophy (XL-SMA) has been linked to changes in the E1 ubiquitin-activating enzyme (Ramser et al., 2008) , implying that altered ubiquitination of motor neuron proteins may result in defective development of the motor unit. In support of this idea, mouse models of SMA have shown that the earliest signs of pathology occur at the neuromuscular junction (NMJ) (Kariya et al., 2008) , indicating that defective maturation of the NMJ may be the initial insult that results in motor neuron disease in SMA patients.
Loss of the proteasomal deubiquitinating enzyme Usp14 in ax J mice (Wilson et al., 2002) results in underdevelopment of several regions of the CNS (D'Amato and Hicks, 1965). Usp14 is expressed during embryogenesis and in adult tissues, including -Tg mice. Muscle weights were determined for six animals per genotype, and values are reported as the average muscle mass Ϯ SE.
Muscle fiber analysis. Gastrocnemius muscles were collected from 4-week-old mice, weighed, and mounted cross-sectionally on cork in OTC medium mixed with tragacanth gum and frozen in liquid-nitrogencooled isopentane (Kim et al., 2005) . All samples were stored at Ϫ80°C. Fiber analysis was conducted on four animals per genotype. Muscle mounts were cut in 6 m serial cross-sections at Ϫ22°C using a Leica CM1900 cryostat microtome and placed on two-well slides (Erie Scientific). Slides were kept in a humidified chamber throughout the staining protocol. All applied solutions were removed by aspiration before administration of the succeeding solution. Sections were fixed for 45 min at room temperature in 3% neutral-buffered formalin. After fixation, sections were washed two times for 5 min with 1ϫ PBS. All subsequent PBS wash steps were three times for 5 min. Sections were blocked with 5% goat serum in PBS for 20 min at room temperature followed by a wash step. Primary and secondary antibodies (Abs) were diluted in PBS containing 1% goat serum. Anti-major histocompatibility complex (MHC) type I primary Ab [mouse monoclonal Ab (mAb) BA-D5, Developmental Studies Hybridoma Bank] was applied for 30 min at 37°C. After a wash step, sections were incubated with Alexa Fluor 586-conjugated goat antimouse secondary Ab (Invitrogen) at a 1:500 dilution for 30 min at 37°C. Sections were washed and again blocked in PBS containing 5% goat serum for 20 min at room temperature. To locate sarcolemmae for myofiber sizing, a wash step was followed by incubation with anti-laminin mouse mAb VP-L551 (NovoCastra Laboratories) at a 1:80 dilution for 30 min at 37°C, a wash step, and incubation with Alexa Fluor 488-conjugated goat anti-mouse secondary Ab (Invitrogen) at a 1:500 dilution for 30 min at 37°C. Slides were then washed and subjected to a third and final block in PBS containing 5% goat serum for 20 min at room temperature. After a wash step, sections were incubated with the final primary Ab (anti-MHC type II mouse mAb My32, Sigma) at a 1:1000 dilution for 30 min at 37°C, washed, and incubated with Alexa Fluor 488-conjugated goat anti-mouse secondary Ab at a 1:500 dilution for 30 min at 37°C. Nuclei were revealed by a Hoechst 33258 DNA counterstain (Invitrogen) used at a 1:10,000 dilution in PBS for 2 min at room temperature. Slides underwent a final aspiration and were mounted with 1% paraphenylene diamine and 50% glycerol in PBS. Slides and coverslips were bound together by use of clear nail polish and stored protected from light at Ϫ20°C. For cross-sectional measurements, 50 random type I and type II myofibers from each animal were manually traced along their laminin-stained border.
Quantitation of motor neuron and axon number. For quantitation of motor neuron numbers, transverse frozen sections of lumbar spinal cords (L4 -L5) from 7-week-old wt and ax J mice were prepared and stained with cresyl violet as described by Blondet et al. (2002) . Images from 10 sequential sections were collected and the area of motor neurons in the ventral horn was measured. For axon number quantitation, 0.5 m cross-sections from L4 -L5 lumbar ventral roots were stained with toluidine blue (n ϭ 5 mice per genotype). The sizes of both motor neurons and axons were measured by using NIS-Elements software (Nikon).
NMJ immunostaining and confocal imaging. For whole-mount immunostaining, mice were anesthetized with ketamine and xylazine (n ϭ 6 mice per developmental time point). Mice were then perfused with PBS, followed with 2% paraformaldehyde (PFA). Tibialis anterior, soleus, diaphragm, and sternomastoid muscles were dissected out and further fixed with 2% PFA. Muscles were teased into fiber bundles and then washed with wash buffer (PBS containing 1% Triton X-100) three times at room temperature for 15 min. Muscle bundles were then blocked with 2% (w/v) BSA and 4% goat serum in wash buffer for 1 h. To label the acetylcholine receptors (AChRs), samples were incubated with 1 g/ml ␣-bungarotoxin-conjugated with tetramethylrhodamine isothiocyanate (TRITC) for 1 h. After being washed three times at room temperature for 15 min with wash buffer, samples from Thy1-Yfp mice were mounted in PBS containing 50% glycerol, and all other samples were incubated with primary Abs for 2 d at 4°C. Primary Abs and their dilutions were as follows: neurofilament heavy chain, 1:400 (Sigma); neurofilament medium chain, 1:1000 (Sigma); synaptophysin, 1:400 (Millipore); SV2 synaptic vesicle proteins, 1:200 (Developmental Studies Hybridoma Bank); S100 protein, 1:200 (DAKO); phosphorylated neurofilaments SMI312, 1:400 (Covance); and Usp14, 1:200 (Crimmins et al., 2006) . After being washed three times for 15 min at room temperature, samples were incubated with secondary Abs conjugated with Alexa Fluor 488, 568, or 643 dye (Invitrogen) at a 1:500 dilution for 1 d at 4°C. For triple immunostaining, neurofilaments were labeled with anti-neurofilament medium chain and anti-neurofilament heavy chain, and synaptic vesicles were labeled with anti-synaptophysin. After being washed three times for 30 min at room temperature, samples were mounted in PBS containing 50% glycerol and then stored at Ϫ20°C.
Quantitative PCR. Total RNA was isolated using RNA-STAT60 (TelTest), and 2 g of the RNA was then reverse transcribed using the Applied Biosystems GeneAmp Gold RNA PCR Reagent Kit. Real-time PCRs were set up in triplicate using TaqMan gene assays and amplified in an Applied Biosystems Step-One instrument. ⌬⌬CCT curves were generated using 18S and GAPDH TaqMan gene assays as internal standards. Quantitative PCR (qPCR) results are shown as the SDs of three different amplifications from RNA that was reverse transcribed from three different mice. Individual gene assay kits were purchased from Applied Biosystems for each of the RNAs analyzed. Paired t tests were conducted on relative quantity values for each group to determine their significance.
Electrophysiology. Intracellular electrophysiological recording was performed as previously described (Dong et al., 2006) . Briefly, diaphragms with ribs and intact phrenic nerves were dissected from adult mice (n ϭ 6 -8 mice per genotype), pinned on Sylgard gel (Ellsworth), and perfused at room temperature for at least 1 h with an oxygenated solution containing the following (in mM): 145 NaCl, 5.4 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 HEPES-NaOH, pH 7.3, and 13 glucose. Microelectrodes, 10 -20 M⍀ when filled with 3 M KCl, were placed in the central region of the muscle fibers in which the AChR clusters were enriched. Positions were adjusted for maximal response with miniature endplate potentials (MEPPs). For recording of nerve-evoked endplate potentials (EPPs), phrenic nerves were sucked into an electrode and stimulated at Ͻ1 mA for a pulse duration of 0.2 ms. For all evoked recordings, 2 M mu-conotoxin GIIIB was used to block muscle contractions. The quantal content was calculated as the mean EPP amplitude/mean MEPP amplitude. Data were collected and analyzed using pClamp 9.2 software (Molecular Devices).
Data are shown as mean Ϯ SEM, where * and # indicate p Ͻ 0.05 and ** represents p Ͻ 0.01.
Immunoblotting. Proteins were resolved on either 8% Tris-glycine gels or 4 -20% Tris-glycine NUPAGE gels (Invitrogen) and transferred onto PVDF membranes. The polyclonal Usp14 R138 antisera (Anderson et al., 2005) ubiquitin Mab1510 (Millipore), neurofilament heavy-chain Ab (Sigma) and anti-␤-tubulin Ab (Developmental Studies Hybridoma Bank) were diluted in PBS containing 3% BSA. Primary Abs were detected using an anti-mouse or anti-rabbit HRP-conjugated secondary Ab (Southern Biotechnology Associates) and luminol reagents (Pierce).
Quantitation of immunoblots. Blots were scanned using a HewlettPackard Scanjet 3970 and quantitated using UN-SCAN-IT software (Silk Scientific). Each value represents the average and SE from four blots using at least three different animals of each genotype.
Synaptosome preparation. Synaptosomes were prepared as described by Dodd et al. (1981) . Briefly, brains were removed and homogenized in 7 ml of ice-cold buffer containing 0.32 M sucrose, 5 mM HEPES, pH 7.4, and protease inhibitor mixture (n ϭ 4 mice per genotype). The homogenate was then centrifuged at 1700 ϫ g for 15 min at 4°C. The supernatant was layered over a 1.2 M sucrose cushion and centrifuged at 105,000 ϫ g for 30 min at 4°C. A protein fraction at the 0.32-1.2 M interface was collected and resuspended in 7 ml of 0.32 M sucrose. This suspension was then layered over a 0.8 M sucrose cushion and centrifuged at 130,000 ϫ g. The resulting pellet was resuspended in RIPA buffer.
Results

ax
J mice have altered muscle development The ax J mice were given the name "ataxia" because of the movement disorders and cerebellar defects observed during postnatal development (Lyon, 1955) . However, our studies on the ax J mice have indicated that the Purkinje cell axonal swellings in the cerebellum (D'Amato and Hicks, 1965) are not the primary cause of the observed motor deficits in these mice (Crimmins et al., 2006) . By 4 -5 weeks of age, the hindlimbs of the ax J mice become inflexible (Fig. 1 A) and the mice rely mainly on their forelimbs for mobility. Although there is no difference in brain weight between wt and ax J mice at 4 -5 weeks of age (Anderson et al., 2005) , the ax J mice have a significant reduction in body mass compared with controls ( Fig. 1 A) . To determine whether muscle mass is also reduced by the loss of Usp14, we compared the weights of gastrocnemius muscles from wt and ax J mice during the first 8 weeks of postnatal development. At 2 weeks of age, the gastrocnemius muscle weights from the ax J mice were indistinguishable from those of their littermate controls (Fig. 1 B) . However, by 4 weeks of age, the gastrocnemius muscle weights of the ax J mice were Ͻ60% of the controls. Although the gastrocnemius muscle weights of the control mice continued to increase during the first 6 weeks of postnatal development, the gastrocnemius muscle weights of the ax J mice showed no increase after 2 weeks of age (Fig. 1 B) . Similar results were observed for the tibialis anterior muscles (data not shown).
To determine whether the reduced muscle weights were caused by a specific effect on either type I or type II muscle fibers in the ax J mice, gastrocnemius muscles from wt and ax J mice were sectioned and stained with antibodies specific for either type I or type II muscle fibers. At 4 weeks, there was a 40% reduction in the cross-sectional area of the type I fibers (700 vs 1120 m 2 ) and a 52% reduction in the size of the type II fibers (685 vs 1410 m 2 ) in the ax J mice compared with controls, suggesting that the muscles in the ax J mice may lack sufficient motor neuron input for normal fiber development and growth. Unlike some mouse models of motor neuron disease, no fiber type grouping or increase in centrally located nuclei was observed in the ax J muscles compared with controls (data not shown).
Loss of Usp14 causes abnormal expression of AChR subunits
The AChR is a pentameric protein complex composed of five subunits of either ␣ 2 ␤␥␦ or ␣ 2 ␤␦ and is responsible for detecting acetylcholine released by motor neurons at the NMJ. Changes in AChR mRNA subunit expression have been observed during postnatal development and after nerve damage. For example, subunit switching from the ␥ subunit to the subunit occurs during postnatal development (Mishina et al., 1986 ) and denervated skeletal muscles undergo atrophy and exhibit increased expression of both embryonic and adult AChR mRNAs (Goldman et al., 1988; Adams et al., 1995) . To determine whether AChR mRNA expression in the ax J mice resembles that observed after muscle denervation, we performed qPCR on RNA isolated from the tibialis anterior muscles of wt and ax J mice at postnatal day 0 (P0), P7, P14, and P28. In both wt and ax J mice, the level of the AChR ␥ subunit mRNA was downregulated (Fig. 2 A) and the subunit mRNA increased (Fig. 2 B) during the first 2 weeks of postnatal growth. Whereas the patterns of expression of all five AChR subunit mRNAs in the ax J and wt mice were similar during the first 2 weeks of postnatal development, the mRNA levels of all five AChR subunits were highly elevated in 4-week-old ax J mice compared with controls ( Fig. 2 A-E) . The loss of Usp14 therefore results in the upregulation of AChR expression in the ax J mice in a manner that is similar to that seen in denervated muscles.
Characterization of the motor neuron circuit in ax J mice To determine whether the ax J movement disorder was caused by a defect in the motor neuron circuit, we first compared the numbers and sizes of the motor neurons in the ventral horn of the lumbar segments that innervate the hindlimbs from the spinal cords of 7-week-old wt and ax J mice, a time point that is close toorders like amyotropic lateral sclerosis and spinal muscular atrophy (Kondo et al., 1986; Cifuentes-Diaz et al., 2002; Kariya et al., 2008; Murray et al., 2008; Kong et al., 2009) . Neurofilament overexpression also leads to aggregation of neurofilaments and motor neuron dysfunction in mice (Lee et al., 1992; Côté et al., 1993; Xu et al., 1993; Collard et al., 1995; Tu et al., 1995; Gama Sosa et al., 2003) . To determine whether loss of Usp14 results in alterations in neurofilament distribution in the ax J mice, motor endplates from P1, P7, and P14 wt and ax J mice were examined by staining tibialis anterior muscles with phosphorylated neurofilament and synaptic vesicle antibodies. Comparison of the staining patterns from P1 mice did not demonstrate any major changes in the development of the motor endplates in the tibialis anterior muscles of the ax J mice compared with controls (Fig. 6) . In wt P7 mice, phosphorylated neurofilaments were restricted to the axons and the most proximal parts of the axon terminals (Fig. 6 ). In the ax J mice, phosphorylated neurofilaments accumulated in focal swellings at P7 axon terminals, in the same areas in which swellings were seen in the images from ax J mice containing the Thy1-Yfp transgene (Fig. 5) . These results indicate that loss of Usp14 results in a developmental defect in the NMJ, and alterations in the cytoskeletal structure may therefore contribute to the disease process in the ax J mice.
www.jneurosci.org as supplemental material). To confirm that the Thy1-Usp14 transgene expressed Usp14 in motor neurons, NMJs from the tibialis anterior muscles of ax J -Tg mice were immunostained for Usp14. The ax J -Tg mice expressed high levels of Usp14 throughout the cell body, the axon, and the nerve terminals ( Fig. 7B ; data not shown). As expected, no Usp14 was detected in the muscles of the ax J -Tg mice (see Fig. 9C ). Usp14 was also found to colocalize with synaptophysin, indicating that Usp14 could directly act at the presynaptic compartment to correct the structural defects at the ax J NMJs. To investigate whether the neuronal expression of Usp14 also corrected both the presynaptic neurofilament accumulation and decreased perforation of the muscle AChRs, we examined the distribution of neurofilaments, synaptophysin, and AChRs in wt, axor axon numbers in the ax J mice. Instead, we observed localized synaptic changes in the structure of the NMJ that included nerve terminal swellings and sproutings, nerve denervation, and neurofilament accumulation. These studies indicate that the ax J mice may serve as a new model to investigate the role of the UPS in diseases that affect motor neurons.
Our investigations of muscle AChR expression also indicated that there is defective nerve and muscle interaction in the ax J mice at 4 weeks of age. Previous studies have shown that muscle denervation results in increased expression of the ␣ , ␤, and ␦ AChR subunits as well as the embryonic AChR ␥ subunit (Merlie et al., 1984; Goldman et al., 1985; Shieh et al., 1987) . During development, mRNA expression of the AChR ␥ subunit is shut off and expression of the AChR subunit mRNA is turned on (Hall and Sanes, 1993) . Muscle denervation results in early increases in ␣␤␥␦ expression, followed several days later by increased AChR subunit expression (Goldman et al., 1985) . In rats, the denervation of muscles has been shown to result in up to 50 -100-fold increases in the expression of AChR subunit mRNAs (Merlie et al., 1984; Goldman et al., 1985) . In comparison, the largest increase in AChR subunit mRNA expression in the ax J muscles at 4 weeks of age was a 30-fold increase in the ␣ subunit mRNA. However, the upregulation in AChR subunit expression in the ax J mice is consistent with a decrease in synaptic input to the muscle and possibly represents an attempt by the muscle to increase nerve-driven muscle activity.
Our studies suggest that the ax J neuromuscular disease is not caused by a loss of motor neurons in the ventral horn. Whereas no changes in total motor neuron number were seen in the ax J mice, we did observe fewer numbers of motor neurons of Ͼ400 m 2 in the ax J mice, which could result from either delayed maturation or increased motor neuron cell death. Since we were unable to detect any difference in activated caspase-3 staining between control and ax J mice, we favor the hypothesis of reduced neuronal development of the "large" motor neurons in the ax J mice. The postnatal maturation of the NMJ involves the pruning of axons from muscles that are innervated by multiple motor neurons, the formation of a highly branched motor axon terminal, and the coordinated expansion of the nerve terminal and muscle fiber that leads to a three-to fourfold increase in the size of the NMJ (Sanes and Lichtman, 1999) . In mice, these events occur during the first 2 weeks of postnatal development, allowing for the rapid growth and maturation of the muscle fibers. The process of motor endplate development is defective in the ax J mice, and large axon terminal swellings and sproutings are observed in several different muscle groups during the first 2 weeks of postnatal development. These axonal swellings and sproutings are enriched in phosphorylated neurofilaments and can be observed in the ax J mice as early as P7. However, it is unclear whether these nerve terminal sproutings represent an attempt at reinnervation of denervated muscles or whether the axon is attempting to make multiple contacts with the muscle to compensate for decreased NMJ activity. In ax J mice, the motor endplates located on the tibialis anterior muscles do not form the branched structure that is observed in wt mice by P14. By 3 weeks of age, the terminal swellings dramatically increase in size and disorganization of the AChR clusters can be seen in the ax J mice, suggesting that the terminal may be degenerating. These results support a model in which Usp14 plays an important role in the formation and function of mature NMJs.
The formation of swollen motor endplates is not uniform across all ax J muscle groups. In contrast to the tibialis anterior muscles, which demonstrate abnormal motor axon terminals at all of the NMJs, approximately half of the NMJ terminals on the diaphragms of the ax J mice appeared to be normal. Differential effects on NMJ pathology have also been reported in a mouse model of SMA, in which the diaphragm exhibited significantly less pathology than the intercostal muscles (Murray et al., 2008) . Our previous studies using diaphragms from 4-to 6-week-old mice suggested that Usp14 is required for synaptic transmission at the NMJ (Wilson et al., 2002) . We also demonstrated that a Thy1-Usp14 transgene could correct the locomotor defects and increase the lifespan of the ax J mice (Crimmins et al., 2006) . Analysis of the expression patterns of the Thy1-Usp14 transgene demonstrated robust expression of Usp14 in the cortex and hippocampus and in the majority of the spinal cord motor neurons. The ax J -Tg mice generated for this current study were phenotypically identical to wild-type mice with respect to muscle mass, strength, and viability (data not shown). Analysis of synaptic activity from the diaphragms of the ax J -Tg mice described in this study demonstrated that restoration of Usp14 exclusively in the nervous system can correct all of the synaptic defects at the ax J NMJ back to near wild-type levels. These results indicate that, in addition to playing a role in NMJ development, Usp14 also functions to maintain synaptic activity at the NMJ.
Usp14 is a proteasome-associated deubiquitinating enzyme that has been shown to be important for maintaining ubiquitin levels in neurons (Borodovsky et al., 2001; Anderson et al., 2005; Crimmins et al., 2006) . Through its association with the proteasome, Usp14 becomes catalytically active and deconjugates ubiquitin from substrates destined for proteasomal degradation (Hu et al., 2005; Crimmins et al., 2006) . By facilitating ubiquitin recycling at the proteasome, Usp14 may act to stabilize ubiquitin pools at synaptic terminals. In support of this idea, loss of Usp14 appears to have the greatest effect on synaptic ubiquitin levels. Unlike total protein fractions, in which no changes in the levels of conjugated ubiquitin are seen between the ax J mice and controls, ubiquitin conjugation in synaptosomal fractions is reduced 40% in the ax J mice compared with controls. The decreased level of ubiquitin protein conjugates in the ax J synaptosomal fraction is consistent with impaired ubiquitin homeostasis at the synapse. Since ubiquitin has been shown to be transported down axons to replenish synaptic ubiquitin levels (Bizzi et al., 1991) , the inability to recycle ubiquitin at the terminals of the motor neurons would have significant affects on the pool of ubiquitin required for targeting proteins for proteasomal degradation. It is also possible that the synaptosomal fraction may represent a more pure neuronal extract, and the differences observed in ubiquitin conjugates between the ax J mice and the controls may be detected only when the background levels of glial ubiquitinated protein conjugates are removed from the total brain extract.
Our studies have also demonstrated that muscle ubiquitin levels are responsive to the expression of Usp14 in the nervous system. Whereas it is possible that stabilization of ubiquitin pools in the muscle may require a specific level of neuronal activity, further studies will be required to determine the role of presynaptic Usp14 in regulating postsynaptic ubiquitin levels.
Although motor neuron disease is typically characterized by a loss of motor neurons, recent reports have demonstrated that the earliest structural defects in mouse models of SMA appear distally and involve the neuromuscular synapse (Kariya et al., 2008; Murray et al., 2008; Kong et al., 2009) . Similar to what we observe in the ax J mice, the SMA phenotypes at the NMJ include poor arborization of axon terminals, presynaptic neurofilament accumulation, impaired maturation of AChR clustering into pretzel-like structures, and reduced muscle development. In addition, mis-sense mutations in the ubiquitin E1-activating enzyme have been linked to XL-SMA (Ramser et al., 2008) , indicating that decreased protein ubiquitination may underlie the disease process in this form of infantile SMA. These findings suggest that a common biochemical pathway may be affected in both the SMA and ax J mice and that further studies on the ax J mice may provide key insights into the pathological mechanisms underlying SMA and other motor neuron disorders.
The data reported in this study show that Usp14 is essential for the postnatal maturation of the peripheral nervous system. It is tempting to speculate that the previously described postnatal defects in the CNS of the ax J mice (D'Amato and Hicks, 1965) are also caused by proteasomal dysfunction and subsequent ubiquitin loss. Since the nervous system undergoes extensive remodeling during postnatal development, maintenance of synaptic levels of ubiquitin is crucial for targeting proteins to the proteasome for degradation. Although the exact role Usp14 plays in NMJ development is not known, we hypothesize that the catalytic activity of Usp14 is critical for ubiquitin recycling at the proteasome. By regulating ubiquitin pools at the nerve terminal, Usp14 would therefore be able to modulate ubiquitin-dependent processes required during synaptic development.
